Drug Trial Radar · NCT07522073
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
588
Planned (sponsor's estimate)
Start
Apr 9, 2026
Primary completion
Sep 15, 2028
Study completion Mar 19, 2029
Sponsor
- Lead sponsor
- Incyte CorporationIncyte (INCY)
- Sponsor type
- Industry
- Collaborators
- Qiagen Manchester Ltd
- First posted
- Apr 13, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of standard chemotherapy with or without INCB161734 in participants with metastatic pancreatic ductal adenocarcinoma (PDAC).
Conditions
- Solid Tumors
Interventions
INCB161734Drug
Oral; tablet
PlaceboDrug
Oral; tablet
Investigator's choice of chemotherapyDrug
The investigator will select the chemotherapy in accordance with the protocol-defined requirements. The possible choices as defined by the protocol:
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival (OS)Time frame: Up to approximately 3 years
- Progression-free survival (PFS) by BICRTime frame: Up to approximately 2 years
- Objective Response by BICRTime frame: Up to approximately 2 years
Locations
230 sites in 22 countries. Site status is shown where the registry gives one.
Investigative Site US058
Birmingham, Alabama · Recruiting
Investigative Site US016
Anchorage, Alaska · Recruiting
Investigative Site US026
Chandler, Arizona · Recruiting
Investigative Site US045
Tucson, Arizona · Recruiting
Investigative Site US051
Duarte, California · Recruiting
Investigative Site US085
Fullerton, California · Not yet recruiting
Investigative Site US054
La Jolla, California · Not yet recruiting
Investigative Site US086
Long Beach, California · Not yet recruiting
Investigative Site US027
Los Angeles, California · Recruiting
Investigative Site US036
Los Angeles, California · Recruiting
Investigative Site US048
Los Angeles, California · Recruiting
Investigative Site US049
Orange, California · Recruiting
Investigative Site US034
San Francisco, California · Recruiting
Investigative Site US001
Santa Monica, California · Recruiting
Investigative Site US071
Denver, Colorado · Recruiting
Investigative Site US013
Washington D.C., District of Columbia · Recruiting
Investigative Site US046
Washington D.C., District of Columbia · Not yet recruiting
Investigative Site US072
Fort Myers, Florida · Recruiting
Investigative Site US083
Jacksonville, Florida · Not yet recruiting
Investigative Site US075
Miami, Florida · Recruiting
Investigative Site US074
St. Petersburg, Florida · Recruiting
Investigative Site US073
West Palm Beach, Florida · Recruiting
Investigative Site US023
Atlanta, Georgia · Recruiting
Investigative Site US079
Chicago, Illinois · Not yet recruiting
Investigative Site US030
Evanston, Illinois · Recruiting
Investigative Site US005
Naperville, Illinois · Recruiting
Investigative Site US009
Springfield, Illinois · Recruiting
Investigative Site US021
Indianapolis, Indiana · Not yet recruiting
Investigative Site US007
New Orleans, Louisiana · Recruiting
Investigative Site US022
Boston, Massachusetts · Recruiting
Investigative Site US006
Ann Arbor, Michigan · Recruiting
Investigative Site US010
Detroit, Michigan · Recruiting
Investigative Site US078
Grand Rapids, Michigan · Recruiting
Investigative Site US012
Ypsilanti, Michigan · Not yet recruiting
Investigative Site US066
Maple Grove, Minnesota · Recruiting
Investigative Site US047
Hattiesburg, Mississippi · Not yet recruiting
Investigative Site US084
Reno, Nevada · Not yet recruiting
Investigative Site US077
Hackensack, New Jersey · Recruiting
Investigative Site US017
Morristown, New Jersey · Recruiting
Investigative Site US059
Lake Success, New York · Recruiting
Showing 40 of 230 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.